AMBER LONG: Open Payments
NPI 1114491966 · BATESVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 55 payments from 11 companies in 2025. Trend: 2023 $1,066 · 2024 $1,394 · 2025 $977
Food & beverage: $893Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $187 |
| ABBVIE INC. | 15 | $181 |
| Lilly USA, LLC | 9 | $134 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $104 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| LEO Pharma Inc. | 3 | $76 |
| GENZYME CORPORATION | 2 | $71 |
| Galderma Laboratories, L.P. | 2 | $43 |
| Organogenesis Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
Products named: TREMFYA, TALTZ, SKYRIZI, DUPIXENT, ILUMYA, COSENTYX, RINVOQ, ADBRY.
Industry payments across AR — which companies pay providers there.
